D-0632-2024 Class II Ongoing
FDA drug recall D-0632-2024 was initiated by FDC Limited on Jul 18, 2024 and is designated Class II. Reason for recall: Defective container; yellow colored spike from cap lodged in the nozzle The recall status is ongoing. Affected quantity: 362,544 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2024
- Initiation Date
- Jul 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 362,544 bottles
Product description
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].
Reason for recall
Defective container; yellow colored spike from cap lodged in the nozzle
Distribution pattern
Nationwide in the US
Code information
Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0632-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026